Drug Topics
APRIL 17, 2024
The ongoing opioid crisis in the United States shows no signs of slowing down. As trusted community health care professionals, pharmacists must play a key role in fighting it.
PharmaVoice
APRIL 15, 2024
The biotech is developing a ‘gene-agnostic’ approach to expand the patient pool for gene therapies.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
IDStewardship
APRIL 14, 2024
In this article a comparison of Rebyota versus Vowst is provided, to help learners differentiate these two fecal microbiota therapies. Authored by: Natalie Boyer, Pharm.D. Candidate 2025 Mentored by: Christina G. O’Connor, Pharm.D., PharmD, BCPS, BCIDP, AAHIV-M Disclaimer : This text and table is intended for use as a study tool to assist people learning pharmacotherapy of recurrent Clostridioides difficile infections (rCDI).
Pharmacy Times
APRIL 17, 2024
If approved, the test could provide more timely and accurate diagnosis, hopefully mitigating the impact of Alzheimer disease (AD) on individuals and the community.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
APRIL 19, 2024
Representatives from the US Government Accountability Office (GAO) interviewed regulators from 5 states on pharmacy benefit manager laws.
PharmaVoice
APRIL 19, 2024
Where Amylyx ultimately failed in ALS, it could prevail in a rare disease. The doctor leading this research explains why.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
APRIL 18, 2024
The results displayed well tolerability and safety with Abrysvo, meeting the study’s co-primary endpoint of immunogenicity and primary safety
Drug Topics
APRIL 18, 2024
As the potential grows to use emerging bispecifics in earlier lines of myeloma therapy, so does the potential to induce better patient outcomes, said Kirollos Hanna, PharmD.
PharmaVoice
APRIL 16, 2024
New clinical trial starts are picking back up, but are still far below their bustling pre-war level.
STAT
APRIL 18, 2024
With H5N1 bird flu spreading to more dairy cow herds, scientists and pandemic experts in this country and abroad are calling on the U.S. government to release more information to help them assess the risk the outbreaks pose to cattle operations and people. Three and a half weeks after first announcing the startling news that cows from a milking herd in Texas had tested positive for H5N1, the government agencies involved in the investigations have not yet revealed what research shows about whethe
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
APRIL 19, 2024
Patients who were formerly incarcerated commonly experience substance use disorder, tuberculosis, hepatitis C, and sexually transmitted diseases
Drug Topics
APRIL 19, 2024
Digital therapeutics are positioned as front-runners in the increasingly digital future of health care.
PharmaVoice
APRIL 17, 2024
As the cliffs approach, pharma companies are tackling the sales hit with diverging strategies.
STAT
APRIL 18, 2024
As two former secretaries of Health and Human Services, we are all too familiar with the struggle of finding narrow openings for bipartisanship. Despite our different approaches, we believe that addressing health care costs is a truly bipartisan issue. To be serious about creating access for people to the best possible care, that care must be affordable for patients and taxpayers.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
APRIL 18, 2024
The results were the longest survival follow-up ever reported for a phase 3 trial for biliary tract cancer.
Drug Topics
APRIL 18, 2024
Nine pharmacists from 2 corporate locations in Wakefield and Westerly are seeking to join the Pharmacy Guild in an attempt to improve working conditions.
Fierce Healthcare
APRIL 17, 2024
Though physicians are quickly growing more comfortable with generative AI, the vast majority expect models to be transparent and trained on credible information, a new
STAT
APRIL 17, 2024
Eli Lilly reported positive results for its obesity drug Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market. The results also pave the way for Zepbound to potentially become the first approved treatment for obstructive sleep apnea, or OSA, a common disorder characterized by breathing interruptions during sleep.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
APRIL 17, 2024
Ustekinumab (Stelara; Janssen Immunology) is a human monoclonal antibody that treats immune-mediated diseases such as psoriasis and psoriatic arthritis.
Drug Topics
APRIL 19, 2024
A Q&A with Joe McKamey, general manager at Marcrom’s Pharmacy in Manchester, Tennessee.
Fierce Healthcare
APRIL 19, 2024
UnitedHealth Group subsidiary Optum appears to have laid off a significant percentage of its workforce, Fierce Healthcare has learned, though the full extent of those job cuts remains unclear. | UnitedHealth Group subsidiary Optum appears to have laid off a significant percentage of its workforce, Fierce Healthcare has learned, though the full extent of those job cuts remains unclear.
STAT
APRIL 17, 2024
The fight against malaria is a test of human intelligence against mosquitoes — and so far, our minuscule winged enemy is winning. But new results shared this week show substantial improvements in one of the most important tools we have to prevent the life-threatening disease: bed nets. Results shared this week by the New Nets Project, an initiative funded by Unitaid and the Global Fund, highlighted a pair of second-generation bed nets tested in endemic areas between 2019 and 2022.
Pharmacy Times
APRIL 14, 2024
Pandemic-related growing pains were common within health care, bringing unique challenges for health systems.
Drug Topics
APRIL 17, 2024
With an unprecedented number of Americans in need of mental health care, what role should pharmacists play when it comes to screenings?
Fierce Pharma
APRIL 17, 2024
One-year data continued to support a more convenient, injectable version of Roche’s blockbuster multiple sclerosis (MS) drug Ocrevus ahead of an FDA decision, the Swiss pharma said. | One-year data continued to support a more convenient, injectable version of Roche’s blockbuster multiple sclerosis drug Ocrevus ahead of an FDA decision, the Swiss pharma said.
STAT
APRIL 14, 2024
As diligent taxpayers breathe a sigh of relief that the hassle of filing their tax forms is over for another year, the Internal Revenue Service continues to let most U.S. hospitals pay nothing in federal taxes. It’s time for Congress to take a hard look at the IRS’s hand in health care. The agency uses a vague “community benefit” standard to liberally grant tax-exempt status to so-called nonprofit hospitals even as many of them are financially taking advantage of sick
Pharmacy Times
APRIL 16, 2024
The campaign for National Stress Awareness Month in April is under way.
Drug Topics
APRIL 17, 2024
Researchers were unable to find a significant benefit for patients for the majority of cancer medications given accelerated FDA approval.
Fierce Healthcare
APRIL 16, 2024
UnitedHealth Group released its first-quarter earnings Tuesday morning as the industry continues to reel from the massive cyberattack on its Change Healthcare unit. | UnitedHealth Group released its first-quarter earnings Tuesday morning as the industry continues to reel from the massive cyberattack on its Change Healthcare unit.
STAT
APRIL 18, 2024
An ongoing investigation into data integrity at Dana-Farber Cancer Institute has resulted in a string of retractions, the latest of which is a 2006 Science paper co-authored by institute president and CEO Laurie Glimcher. The retraction notice, published in Science on Thursday, noted that the authors had become aware of discrepancies in key scientific images that led them to lose confidence in key figures in the study, although the study’s lead author opposed the retraction.
Pharmacy Times
APRIL 19, 2024
Individuals treated with chemotherapy following a breast cancer diagnosis were more at risk of developing second primary lung cancer.
Drug Topics
APRIL 15, 2024
In the United States, 12 million adults suffer from co-occurring chronic pain and anxiety or depression. Erasing stigmas, educating patients, and tailoring interventions can help to improve outcomes.
Fierce Healthcare
APRIL 14, 2024
Medical records software giant Epic and venture-backed health tech company Particle Health are mired in an ongoing dispute over healthcare data exchange practices. | Health IT experts say the rift between the two companies exposes larger problems with health data exchange including a lack of transparency on who is accessing data and how it's being used along with the need for better gatekeeping.
Expert insights. Personalized for you.
502 
Let's personalize your content